New Zealand vs Uganda: Share of the population living with HIV receiving antiretroviral therapy
New Zealand
84.2%
in 2024
Uganda
84.7%
in 2024
New Zealand rank
41st
Uganda rank
40th
Share of the population living with HIV receiving antiretroviral therapy over time
- New Zealand
- Uganda
How they compare
Uganda currently reports 84.7% against 84.2% in New Zealand, a difference of 0.5%.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Uganda ahead.
New Zealand ranks 41st and Uganda ranks 40th of 149 countries.
Across the 4 decades both report, New Zealand averaged higher in 3 and Uganda in 1.
Head to head by decade
| Decade | New Zealand | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 13.4% | 0.0% | 13.4% | New Zealand |
| 2000s | 43.2% | 6.5% | 36.7% | New Zealand |
| 2010s | 64.2% | 48.7% | 15.5% | New Zealand |
| 2020s | 79.2% | 79.9% | 0.8% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, New Zealand or Uganda?
- Uganda, at 84.7% against 84.2% in New Zealand as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between New Zealand and Uganda?
- 0.5%, with Uganda ahead.
- How many years of comparable data are there for New Zealand and Uganda?
- 35 years are reported by both, from 1990 to 2024.
- How do New Zealand and Uganda rank globally for share of the population living with hiv receiving antiretroviral therapy?
- New Zealand ranks 41st and Uganda ranks 40th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.